Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.21/16092 |
Resumo: | Healthcare-associated methicillin-resistant Staphylococcus aureus infections represent extremely high morbidity and mortality rates worldwide. We aimed to assess the antimicrobial potential and synergistic effect between Epigalocatenin-3-gallate (EGCG) and different antibiotics in S. aureus strains with divergent resistance phenotypes. EGCG exposure effects in epigenetic and drug resistance key modulators were also evaluated. S. aureus strains (n = 32) were isolated from infected patients in a Lisbon hospital. The identification of the S. aureus resistance phenotype was performed through automatized methods. The antibiotic synergistic assay was performed through disk diffusion according to EUCAST guidelines with co-exposure to EGCG (250, 100, 50 and 25 µg/mL). The bacteria’s molecular profile was assessed through FTIR spectroscopy. The transcriptional expression of OrfX, SpdC and WalKR was performed by using qRT-PCR. FTIR-spectroscopy analysis enabled the clear discrimination of MRSA/MSSA strains and the EGCG exposure effect in the bacteria’s molecular profiles. Divergent resistant phenotypes were associated with divergent transcriptional expression of the epigenetic modulator OrfX, particularly in MRSA strains, as well as the key drug response modulators SpdC and WalKR. These results clearly demonstrate that EGCG exposure alters the expression patterns of key epigenetic and drug response genes with associated divergent-resistant profiles, which supports its potential for antimicrobial treatment and/or therapeutic adjuvant against antibiotic-resistant microorganisms. |
id |
RCAP_187027a7017305ddecbf389a64b0cc00 |
---|---|
oai_identifier_str |
oai:repositorio.ipl.pt:10400.21/16092 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypesHealthcare-associated S. aureus infectionsEpigallocatechin-3-gallate (EGCG)Synergistic effectsDrug resistance phenotypesEpigenetic modulatorDrug resistance modulatorsHealthcare-associated methicillin-resistant Staphylococcus aureus infections represent extremely high morbidity and mortality rates worldwide. We aimed to assess the antimicrobial potential and synergistic effect between Epigalocatenin-3-gallate (EGCG) and different antibiotics in S. aureus strains with divergent resistance phenotypes. EGCG exposure effects in epigenetic and drug resistance key modulators were also evaluated. S. aureus strains (n = 32) were isolated from infected patients in a Lisbon hospital. The identification of the S. aureus resistance phenotype was performed through automatized methods. The antibiotic synergistic assay was performed through disk diffusion according to EUCAST guidelines with co-exposure to EGCG (250, 100, 50 and 25 µg/mL). The bacteria’s molecular profile was assessed through FTIR spectroscopy. The transcriptional expression of OrfX, SpdC and WalKR was performed by using qRT-PCR. FTIR-spectroscopy analysis enabled the clear discrimination of MRSA/MSSA strains and the EGCG exposure effect in the bacteria’s molecular profiles. Divergent resistant phenotypes were associated with divergent transcriptional expression of the epigenetic modulator OrfX, particularly in MRSA strains, as well as the key drug response modulators SpdC and WalKR. These results clearly demonstrate that EGCG exposure alters the expression patterns of key epigenetic and drug response genes with associated divergent-resistant profiles, which supports its potential for antimicrobial treatment and/or therapeutic adjuvant against antibiotic-resistant microorganisms.MDPIRCIPLMira, Ana RitaZeferino, Ana SofiaInácio, RaquelDelgadinho, MarianaBrito, MiguelCalado, CecíliaRibeiro, Edna2023-05-22T10:16:59Z2023-03-042023-03-04T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.21/16092engMIRA, Ana Rita; [et al] – Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes. Antibiotics. eISSN 2079-6382. Vol. 12, N.º 3 (2023), pp. 1-16.10.3390/antibiotics120305192079-6382info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-08-03T10:14:23Zoai:repositorio.ipl.pt:10400.21/16092Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T20:23:41.463047Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
title |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
spellingShingle |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes Mira, Ana Rita Healthcare-associated S. aureus infections Epigallocatechin-3-gallate (EGCG) Synergistic effects Drug resistance phenotypes Epigenetic modulator Drug resistance modulators |
title_short |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
title_full |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
title_fullStr |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
title_full_unstemmed |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
title_sort |
Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes |
author |
Mira, Ana Rita |
author_facet |
Mira, Ana Rita Zeferino, Ana Sofia Inácio, Raquel Delgadinho, Mariana Brito, Miguel Calado, Cecília Ribeiro, Edna |
author_role |
author |
author2 |
Zeferino, Ana Sofia Inácio, Raquel Delgadinho, Mariana Brito, Miguel Calado, Cecília Ribeiro, Edna |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
RCIPL |
dc.contributor.author.fl_str_mv |
Mira, Ana Rita Zeferino, Ana Sofia Inácio, Raquel Delgadinho, Mariana Brito, Miguel Calado, Cecília Ribeiro, Edna |
dc.subject.por.fl_str_mv |
Healthcare-associated S. aureus infections Epigallocatechin-3-gallate (EGCG) Synergistic effects Drug resistance phenotypes Epigenetic modulator Drug resistance modulators |
topic |
Healthcare-associated S. aureus infections Epigallocatechin-3-gallate (EGCG) Synergistic effects Drug resistance phenotypes Epigenetic modulator Drug resistance modulators |
description |
Healthcare-associated methicillin-resistant Staphylococcus aureus infections represent extremely high morbidity and mortality rates worldwide. We aimed to assess the antimicrobial potential and synergistic effect between Epigalocatenin-3-gallate (EGCG) and different antibiotics in S. aureus strains with divergent resistance phenotypes. EGCG exposure effects in epigenetic and drug resistance key modulators were also evaluated. S. aureus strains (n = 32) were isolated from infected patients in a Lisbon hospital. The identification of the S. aureus resistance phenotype was performed through automatized methods. The antibiotic synergistic assay was performed through disk diffusion according to EUCAST guidelines with co-exposure to EGCG (250, 100, 50 and 25 µg/mL). The bacteria’s molecular profile was assessed through FTIR spectroscopy. The transcriptional expression of OrfX, SpdC and WalKR was performed by using qRT-PCR. FTIR-spectroscopy analysis enabled the clear discrimination of MRSA/MSSA strains and the EGCG exposure effect in the bacteria’s molecular profiles. Divergent resistant phenotypes were associated with divergent transcriptional expression of the epigenetic modulator OrfX, particularly in MRSA strains, as well as the key drug response modulators SpdC and WalKR. These results clearly demonstrate that EGCG exposure alters the expression patterns of key epigenetic and drug response genes with associated divergent-resistant profiles, which supports its potential for antimicrobial treatment and/or therapeutic adjuvant against antibiotic-resistant microorganisms. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-05-22T10:16:59Z 2023-03-04 2023-03-04T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.21/16092 |
url |
http://hdl.handle.net/10400.21/16092 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
MIRA, Ana Rita; [et al] – Epigenetic and drug response modulation of epigalocaten-in-3-gallate in staphylococcus aureus with divergent resistance phenotypes. Antibiotics. eISSN 2079-6382. Vol. 12, N.º 3 (2023), pp. 1-16. 10.3390/antibiotics12030519 2079-6382 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799133509479038976 |